Wright Medical Group has commercially launched FUSIONFLEX Demineralized Moldable Scaffold, a novel form of demineralized bone matrix made from 100% allograft.
FUSIONFLEX is designed for use in conjunction with hardware in primary fusion procedures of the lower extremities, as well as other orthopaedic bone grafting applications.
The scaffold expands Wright’s market-leading portfolio of hardware and ortho-biologic products for the orthopaedic foot and ankle surgeon and will be made available immediately in the US through Wright’s specialized foot and ankle sales force.
The FUSIONFLEX scaffold builds on the safety and efficacy of Wright’s allograft platform and long-standing partnership with AlloSource.
Wright Medical Group Upper Extremity and Biologics senior director Eric Gay said following minimal preparation, FUSIONFLEX scaffold readily absorbs biologic agents, such as bone marrow aspirate (BMA) and platelet-rich plasma (PRP), resulting in an intraoperatively-flexible graft at a relatively low cost.
FUSIONFLEX scaffold is the latest addition to Wright’s Biologics franchise, which includes products such as PRO-STIM Injectable Inductive Graft, XPANSION Skin Grafting Instruments, PRO-DENSE Injectable Regenerative Graft, GRAFTJACKET Regenerative Tissue Matrix, BIOTAPE XM Reinforcement Matrix, OSTEOSET T Medicated Bone Graft (not available in the US), and the ALLOPURE line of foot and ankle bone wedges.